Utility of Vascular Endothelial Growth Factor Inhibitors in the Treatment of Ovarian Cancer: From Concept to Application

Despite recent advances in the management of ovarian cancer, it remains the most lethal gynecologic malignancy. Vascular endothelial growth factor (VEGF) has been shown to play a pivotal role in the progression of ovarian cancer leading to the eventual development of malignant ascites. On this basis...

Descripción completa

Detalles Bibliográficos
Autores principales: Amini, Afshin, Masoumi Moghaddam, Samar, Morris, David L., Pourgholami, Mohammad H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180777/
https://www.ncbi.nlm.nih.gov/pubmed/21961001
http://dx.doi.org/10.1155/2012/540791

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180777/
https://www.ncbi.nlm.nih.gov/pubmed/21961001
http://dx.doi.org/10.1155/2012/540791

Ejemplares similares